Similar to the PD‐1/PD‐L1 axis, TIGIT exerts an immunosuppressive effect in tumor immune surveillance, thereby promoting the progression of HCC [20, 21]. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.